BaumannJ. M., BisazS., FelixR., FleischH., GanzU., RusselR. G. G.: The role of inhibitors and other factors in the pathogenesis of recurrent calcium containing renal stones. Clin. Sci. Mol. Med., 53; 141 (1977).
2.
BaumannJ. M., GanzU., BisazS., FleischH., RutishauserG.: Verabreichung eines Diphosphonates zur Steinprophylaxe. Helv. Chir. Acta, 41; 421 (1974).
3.
BaumannJ. M., WackerM.: The treatment of recurrent calcium nephrolithiasis with ethane-1-hydroxy-1,1-diphosphonate (EHDP). Etidronate (Proc. of 1st Intern. Symposium on Diphosphonate in Therapy, Rome march 1979), p. 167, A. Caniggia ed.; pubbl. 1st. Gentili, Pisa 1980.
4.
BurdetteD. C., ThomasW. C., FinlaysonB. J.: Urinary supersaturation with calciumoxalate before and during orthophosphate therapy. J. Urol., 115; 418 (1976).
5.
CoeF. L.: Nephrolithiasis. Pathogenesis and treatment. Year Book Med. Publ., Chicago1978.
6.
CoeF. L., KavalachA. G.: Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N. Eng. J. Med., 291; 1344 (1974).
7.
FraserD., RusselR. G., PohlerO., RobertsonW. G., FleischH.: The influence of Disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on the development of experimentally induced urinary stones in rats. Clin. Sci. Mol. Med., 42; 197 (1972).
8.
MalekS., BoyceW. H.: Observations on ultrastructure and genesis of urinary calculi. J. Urol., 117; 336 (1977).
9.
MicaliF., PorenaM., VespasianiG.: La calcolosi urinaria. Ed. Wellcome, Pomezia1979.
10.
NordinB. E. C, RobertsonW. G., BarryH., BulusuL., SpeedR.: Rein et calcium. Ed. HiocoD., p. 345. Sandoz Editions, Rueil-Malmaison1974.
11.
OhataM., PakC. Y. C.: The effect of diphosphonate on calcium phosphate crystallization in urine in vitro. Kidney Intern., 4; 401 (1973).
12.
OhataM., PakC. Y. C.: Preliminary study of the treatment of nephrolithiasis (calcium stones) with disphosphonates. Metabolism, 23; 1167 (1974).
13.
OliverI., WeinbergerA., Bar-MeirS., SperlingO., JahavJ., De VriesA.: Orthophosphate treatment of calcium Iithiasis associated with idiopathic hypercalciuria. Urol. Intern., 29; 414 (1974).
14.
PakC. Y., WatersO., ArnoldR. L., HoltK., CoxC., BarillaD.: Mechanism for calcium urolithiasis among patients with hyperuricosuria. J. Clin. Invest., 59; 426 (1977).
15.
PietrekJ., KokotF.: Treatment of patients with calcium containing renal stones with cellulase phosphate. Brit. J. Urol., 45; 136 (1973).
16.
ReckerR. R., HassingG. S., LauJ. R., SavilleP. D.: The hyperphosphatemic effect of disodium ethane-1-hydroxy-1,1-disphosphonate: renal handling of phosphorus and the renal response to parathyroid ormone. J. Lab. Clin. Med., 81; 258 (1973).
17.
RobertsonW. G., MarshallR. W., PeacockM.: Treatment of calcium stone disease with disphosphonate (ethane-1-hydroxy-1,1-disphosphonate). Etidronate (Proc. of 1st Intern. Symposium on Disphosphonate in Therapy, Rome march 1979), p. 147. CaniggiaA. ed.; pubbl. Ist. Gentili, Pisa1980.
18.
RobertsonW. G., PeacockM.: Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin. Sci., 43; 499 (1972).
19.
RobertsonW. G., PeacockM., HeyburnP. J., MarshallD. H., ClarkP. B.: Risk factors in calcium stone disease of the urinary tract. Brit. J. Urol., 50; 449 (1978).
20.
RobertsonW. G., PeacockM., MarshallR. W.: Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N. Engl. J. Med., 294; 249 (1976).
21.
RobertsonW. G., PeacockM., MarshallR. W., KnowlesF.: The effect of ethane-1-hydroxy-1,1-disphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stone-formers. Clin. Sci. Mol. Med., 47; 13 (1974).
22.
SmithM. J. V: Placebo versus allopurinol for renal calculi. J. Urol., 117; 690 (1977).
23.
SmithM. J. V, HuntL. D., KingJ. S., BoyceW. H.: Uricemia and urolithiasis. J. Urol., 101; 637 (1969).
24.
SmithL. H., ThomasW. C., ArnaudC. D.: Urinary calculi. Ed. by DelatteL. C., RapadoA. and HodgkinsonA., p. 188. Karger, Basel1973.
25.
VermeulenC. W., FinlaysonB., ChapmanN.: Influence of urinary glycuronide on solubility of calcium phosphate and stone formation: experimental urolithiasis. J. Urol., 77; 685 (1957).
26.
WaltonR. J., RusselR. G. G., SmithR.: Changes in renal and extrarenai handling of phosphate induced by disodium ethidronate (EHDP) in man. Clin. Sci, Mol. Med., 49; 45 (1975).
27.
YendtE. J., GuayG. F., GarciaD. A.: The use of thiazides in the prevention of renal calculi. Can. Med. Ass. J., 102; 614 (1970).